Skip to Main Content

Paper Details

Multisystem Inflammatory Syndrome therapies in children (MISTIC): A randomized trial.
Contemp Clin Trials Commun
2
2023
Children, IVIG, Kawasaki disease, MIS, MIS-C, Multisystem Inflammatory Syndrome, Participants, SARS, SARS-CoV-2, children, coronary artery vasculitis, fever, inflammation, infliximab, participants, patients
Author NameAffiliation
Sonia JainBiostatistics Research Center, Herbert Wertheim School of Public Health and Human Longevity Science, University of California at San Diego
Feng HeBiostatistics Research Center, Herbert Wertheim School of Public Health and Human Longevity Science, University of California at San Diego
Adriana H Tremouletuniversity of california san diego School of Medicine/Rady Children's Hospital San Diego
  • 1 - 3

Datasets

Release 1.2